Please assess the completion status of the following clinical trial:

Trial Title: Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Understand and sign the informed consent form~* Age 18-65~* Healthy on the basis of Physical Exam~* Treatment with a single antidepressant 4 weeks prior to study start and willingness to maintain on stable dose of the same antidepressant throughout the study~* Current diagnosis of Major Depressive Disorder~* Judgement of the clinician that the subject has shown a sub-optimal response to the antidepressant~Exclusion Criteria:~* Presence of other serious medical illness(es)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).